Clinical Studies for the Treatment of Advanced Solid Tumors

Clinical trial NCT06825494 · RECRUITING

Trial details

NCT number: NCT06825494
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2025-04-08
Primary completion: 2026-03-01
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.